Trial intelligence / Profile preview

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT)

NCT05045950Phase 2Recruiting

Sponsor
Medical College of Wisconsin
Start
Nov 2021
Primary completion
May 2028
Countries
1
01

Overview

Phase 2, open-label, single-arm trial in brain metastases, sponsored by Medical College of Wisconsin. Primary endpoint: Successful completion of PRDR WBRT treatment at 5 days. Started Nov 2021; status: recruiting.

02

Conditions

brain metastases

Beyond the preview

Go deeper on NCT05045950.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05045950.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call